ATLASPLAN
510(k) K980584
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK980584 | Date18 May 1998 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- HAW
- Device Class
- Class II
- Regulation
- 21 CFR Part 882.4560
- Advisory Committee
- Neurology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 27 Sep 2026
ATLASPLAN is a software system designed to guide neurosurgeons in the planning of functional procedures on the brain. It allows fine-tuning of target coordinates, determining the anatomical extent of target boundaries, and planning the optimal trajectory. The image is translated and scaled down to match patient image sets from CT or MR images.
ATLASPLAN is a Class 2 Neurology device with product code HAW, cleared by the FDA through the Traditional 510(k) pathway under K980584. It was found substantially equivalent and received clearance on May 18, 1998. The device is supplied as a software system for use in neurosurgical planning environments.
Other devices from Radionics, Inc.
Questions
AI-generated answers, 27 Sep 2026
What is ATLASPLAN used for?
ATLASPLAN is a software system designed to guide neurosurgeons in planning functional procedures on the brain. It enables fine-tuning of target coordinates, determination of anatomical target boundaries, and planning of optimal surgical trajectories by translating and scaling images to match patient CT or MR datasets.
How is ATLASPLAN supplied and what type of device is it?
ATLASPLAN is supplied as a software system intended for use in neurosurgical planning environments. It is classified as a Class 2 Neurology device with product code HAW, meaning it is a digital tool that supports preoperative planning rather than a physical implant or instrument.
What regulatory pathway was used for ATLASPLAN’s clearance?
ATLASPLAN received FDA clearance through the Traditional 510(k) pathway under submission K980584. It was determined to be substantially equivalent to a predicate device and was cleared on May 18, 1998, based on its intended use and technological characteristics.